Advanced search
Publication Cover
HIV Clinical Trials Volume 2, 2001 - Issue 6
Submit an article Journal homepage
128
Views
55
CrossRef citations to date
0
Altmetric
Original Articles

Health-Related Quality of Life in Individuals Infected with HIV in the Era of HAART

Alexander H. MinersHealth Economics Research GroupBrunel University, Uxbridge, LondonCorrespondence[email protected].
,
Caroline A. SabinRoyal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London
,
Amanda MocroftRoyal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London
,
Mike YouleRoyal Free Centre for HIV Medicine, Department of Thoracic Medicine, Royal Free Hospital, London and NPMS-HHC, St. Stephen’s Centre, Chelsea & Westminster Hospital, London
,
Martin FisherDepartment of HIV/Genitourinary MedicineBrighton Health Care NHS Trust, Brighton
&
Margaret JohnsonRoyal Free Centre for HIV Medicine, Department of Thoracic Medicine, Royal Free Hospital, London, United Kingdom
Pages 484-492 | Published online: 02 Feb 2015

REFERENCES

  • Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352:1725–1730.
  • Palella FJJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860.
  • Wu A. Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS. 2000;14:1449–1451.
  • Badia X, Podzamczer D, Garcia M, Lopez- Lavid CC, Consiglio E. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQ0L-HIV Validation Group. Medical Outcomes Study HIV Health Survey. AIDS. 1999;13:1727–1735.
  • Nieuwkerk PT, Gisolf EH, Colebunders R, et al. Quality of life in asymptomatic and symptomatic HIV infected pa-tients in a trial of ritonavir/saquinavir therapy. AIDS. 2000;14:181–187.
  • Carr A, Chuah J, Hudson J, et al. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: The OzCombo1 study. AIDS. 2000;14:1171–1180.
  • Franchi D,Wenzel RP. Measuring health-related quality of life among patients infected with human immunodeficiency virus. Clin Infect Dis. 1998;26:20–26.
  • Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr. 1997;16:350–356.
  • Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29:786–798.
  • The EuroQol Group. EuroQol - a new facility for the mea-surement of health related quality of life. Health Policy. 1994;16:655–662.
  • Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care. 1998;36:126–137.
  • Williams A. The Measurement and Valuation of Health: A Chronicle. University of York: Centre for Health Econom-ics; 1995. Discussion Paper 136.
  • Kind P, Dolan P, Gudex C, Williams A. Variations in popula-tion health status: Results from a United Kingdom national questionnaire survey. Brit Med J. 1998;316:736–741.
  • Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applica-tions of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Res. 1997;6:531–554.
  • Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Res. 1997;6:481–493.
  • Burgess A, Dayer M, Catalan J, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis. AIDS. 1993;7:1001–1008.
  • Revicki D, Wu AW, Murray MI. Change in clinical status, health status and health utility outcomes in HIV infected patients. Med Care. 1995;33:AS173-AS182.
  • Ganz PA, Coscarelli SC, Kahn B, Petersen L, Hirji K. De-scribing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems—Evaluation System (HOPES). Quality of Life Res. 1993;2:109–119.
  • Scott-Lennox JA, Wu AW, Boyer JG, Ware JE Jr. Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey. Med Care. 1999;37:908–925.
  • Miller V, Sabin CA, Phillips AN, Rottmanm C, Rabenau H, Weidermann E. The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. AIDS. 2000;14:2129–2136.
  • Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with hu-man immunodeficiency virus infection. J Infect Dis. 2000;181:946–953.
  • Wu AW, Jacobson DL, Berzon RA, et al. The effect of mode of administration on medical outcomes study health rat-ings and EuroQol scores in AIDS. Quality of Life Res. 1997;6:3–10.
  • Trueman P, Dolan P, Sawyer W. Quality of life in a treated HIV population. Sixth Annual Conference of the Interna-tional Society for Quality of Life Research; 1998.
  • Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evalua-tion. Health Technol Assess. 1999;3(9).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.